This dual-targeting Co-Assembled formulation exhibits cytotoxic effects on AML cells (AML cell lines and primary blasts), reduced leukemia burden and prolonged survival in FLT3-ITD AML mouse models. This evidence concerns the gene FLT3 and acute myeloid leukemia.